Treatment of symptomatic diabetic peripheral neuropathy with the protein kinase C beta-inhibitor ruboxistaurin mesylate during a 1-year, randomized, placebo-controlled, double-blind clinical trial (Q44914002)
scientific article
Language:
(P31) (Q13442814)
(P50) (Q42699005)
(Q57260013)
(P304) 1164-1180
(P433) 8
(P478) 27
(P577) Monday, August 1, 2005
(P921) (Q269829)
(Q945238)
(P1433) (Q15716601)
(P1476) "Treatment of symptomatic diabetic peripheral neuropathy with the protein kinase C beta-inhibitor ruboxistaurin mesylate during a 1-year, randomized, placebo-controlled, double-blind clinical trial" (language: en)
(P2093) Aaron I Vinik
Peter Kempler
William J Litchy
Karen L Price
Edward J Bastyr
MBBQ Study Group
other details
description scientific article

External Links